What does CUSIP 29970R105 represent in this 13F holders report?

CUSIP 29970R105 is the security identifier for EVAX - EVAXION BIOTECH A S - ADS used to aggregate holder disclosures.

How many institutions held EVAX - EVAXION BIOTECH A S - ADS in Q4 2021?

11 institutional investors reported EVAX - EVAXION BIOTECH A S - ADS for Q4 2021. Use the holders table for investor-level position and value details.

EVAXION BIOTECH A S - ADS (EVAX)

CUSIP: 29970R105

Q4 2021 13F Holders as of 31 Dec 2021

Security type / class: Equity / ADS
Total 13F shares: 1,077,414
Total 13F value: $4,763,000
Share change: +737,132
Put/Call ratio: 9%
SEC-reported price per share: $4.42
Number of holders: 11
Value change: +$1,884,508
Number of buys: 11
Number of sells: 2

Security key

29970R105

Report period

Q4 2021

Institutions

Top holders

EVAX full security history Ownership snapshot Full 13F holder table Evaxion A/S SEC filings Evaxion A/S company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of EVAX - EVAXION BIOTECH A S - ADS (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Maven Securities LTD

Disclosed value leader

Maven Securities LTD

Comparable rows

0/7

Latest evidence

30 Sep 2021

13F Highest disclosed value: $2,148,000 7 rows are not safely comparable across share classes. Showing 1-6 of 7 holder rows.

Quick read

Maven Securities LTD has the largest disclosed position value at $2.15M.

0 of 7 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Maven Securities LTD's linked filing trail.

Disclosed position value Top 5

Maven Securities LTD $2.15M

CREDIT SUISSE AG/ $389K

Kepos Capital LP $358K

Telemetry Investments, L.L.C. $296K

ETF MANAGERS GROUP, LLC $64K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 7 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Maven Securities LTD	13F Company 13F	— denominator unverified	$2,148,000 222,806 shares	—	30 Sep 2021
CREDIT SUISSE AG/	13F Company 13F	— denominator unverified	$389,000 40,315 shares	—	30 Sep 2021
Kepos Capital LP	13F Company 13F	— denominator unverified	$358,000 37,098 shares	—	30 Sep 2021
Telemetry Investments, L.L.C.	13F Company 13F	— denominator unverified	$296,000 30,743 shares	—	30 Sep 2021
ETF MANAGERS GROUP, LLC	13F Company 13F	— denominator unverified	$64,000 6,859 shares	—	30 Sep 2021
UBS Group AG	13F Company 13F	— denominator unverified	$22,000 2,261 shares	—	30 Sep 2021

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2021

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

1,077,414

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

Q4 2021 holders

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 value	Q4 2021 value	Value change	Value Chg %